Proposed Data Collection Submitted for Public Comment and Recommendations, 27316-27318 [2015-11512]
Download as PDF
<![CDATA[
27316
Federal Register / Vol. 80, No. 92 / Wednesday, May 13, 2015 / Notices
reportable conditions, which include
infectious and non-infectious diseases,
vary by jurisdiction depending upon
each jurisdiction’s health priorities and
needs. Infectious disease agents and
environmental hazards often cross
geographical boundaries. Each year, the
Council of State and Territorial Disease
Epidemiologists (CSTE), supported by
CDC, determines which reportable
conditions should be designated
nationally notifiable and voluntarily
submitted to CDC so that information
can be shared across jurisdictional
boundaries and both surveillance and
prevention and control activities can be
average burden per response based on
the burden tables from all of the
consolidated applications has not
changed. The burden on the states and
cities is estimated to be 10 hours per
response and the burden on the
territories is estimated to be 5 hours per
response. The addition of new vaccine,
laboratory, and disease-specific data
elements do not add any additional
burden because the states, territories,
and cities already collect those data
elements. There will be no increase in
burden for the states, territories, and
cities to send those data elements to
CDC. The estimated annual burden is
28,340 hours.
coordinated at regional and national
levels.
CDC requests a three-year approval for
a revision the NNDSS information
collection. This Revision includes
requests for approval to receive: (1) Case
notification data for Chikungunya,
Dengue-like illness, Non-HPS
Hantavirus, and Acute Flaccid Myelitis;
(2) new laboratory and vaccine data
elements for all conditions; and (3) new
disease-specific data elements for
Mumps, Pertussis, and Sexually
Transmitted Diseases.
Although this Revision includes case
notifications that were not part of the
last NNDSS Revision, the estimate of the
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Avg. burden
per response
(in hrs.)
Total burden
(in hrs.)
Type of respondents
Form name
States ................................................
Territories ..........................................
Cities .................................................
Weekly and Annual ..........................
Weekly and Annual ..........................
Weekly and Annual ..........................
50
5
2
52
52
52
10
5
10
26,000
1,300
1,040
Total ...........................................
...........................................................
........................
........................
........................
28,340
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–11514 Filed 5–12–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Written comments must be
received on or before July 13, 2015.
DATES:
Centers for Disease Control and
Prevention
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention, CDC, Department of Health
and Human Services, HHS.
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a new information
asabaliauskas on DSK5VPTVN1PROD with NOTICES
VerDate Sep<11>2014
17:27 May 12, 2015
Jkt 235001
You may submit comments,
identified by Docket No. CDC–2015–
0032 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
ADDRESSES:
[60 Day–15–15AGK; Docket No. CDC–2015–
0032]
SUMMARY:
collection request entitled,
‘‘Understanding Barriers and
Facilitators to HIV prevention for Men
Who Have Sex with Men (MSM)’’ to
conduct qualitative research with most
at risk HIV-negative MSM. The research
is intended to understand issues
surrounding HIV risk for MSM, identify
influences of high risk behaviors and to
investigate risk management and
resiliency among HIV-negative MSM.
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\13MYN1.SGM
13MYN1
27317
Federal Register / Vol. 80, No. 92 / Wednesday, May 13, 2015 / Notices
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Understanding Barriers and
Facilitators to HIV prevention for Men
Who Have Sex with Men (MSM) (Pulse
Study)—New—National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
(NCHHSTP)/Division of HIV/AIDS
Prevention (DHAP) is requesting
approval for one year of a data
collection entitled, ‘‘Understanding
mouth referrals or flyers given out by
community-based, advocacy, faithbased, and service-providing agencies.
Primarily, we will use a qualitative
research design and will include a brief
quantitative survey to reduce
participant burden where possible (for
example, when we do not need to know
an in-depth answer for sociodemographics, HIV testing history,
housing status, health insurance status).
The first portion of the interview
instrument consists of brief structured
questions to characterize the
respondents. The second portion of the
instrument consists of open-ended indepth qualitative questions. This
research design was chosen based on
the exploratory nature of our study
purpose.
All data collection tools will be pretested and interviews conducted by
trained personnel. The data collection
will take place at a time and place that
is convenient to the respondent.
Locations will be private. Data
collection may be audio-recorded and
transcribed with the consent of the
respondent.
We anticipate that consent forms and
screener forms to take five minutes to
complete each. We anticipate 50 percent
of HIV-negative MSM screened will be
eligible for the study. The brief
structured survey (15 minutes) and indepth interview (45 minutes) for HIVnegative MSM are expected to take a
total of 60 minutes (1 hour) total. We
will complete interviews for 105 black/
African-American and 45 Hispanic/
Latino HIV-negative MSM at greatest
risk for HIV in high prevalence cities in
the U.S. South. We anticipate screening
300 potential respondents. The total
number of burden hours are 192.
Barriers and Facilitators to HIV
prevention for Men Who Have Sex with
Men (MSM).’’ The purpose of this study
is to conduct primarily qualitative
research with most at risk HIV-negative
MSM. There are four goals to this study:
(1) Understand issues surrounding HIV
risk for MSM; (2) learn more about how
gay community or peer norms, and
community identification influence risk
behaviors; (3) understand individual
HIV risk management, such as having an
HIV-positive partner with suppressed
viral load, barriers and facilitators for
use of biomedical interventions (i.e.,
pre-exposure prophylaxis (PrEP), nonoccupational post-exposure prophylaxis
(nPEP); and (4) understand factors that
promote resiliency among HIV-negative
MSM.
The present research will be
conducted in the top five Southern
metropolitan areas in the United States
with the highest HIV diagnoses for
MSM—Atlanta, Georgia; Jackson,
Mississippi; Miami, Florida; and New
Orleans and Baton Rouge, Louisiana.
These cities rank among those in the
South with the highest prevalence and
incidence of HIV and sexually
transmitted infections (STIs) among
black/African American and Hispanic/
Latino MSM.
The study population will consist of
black/African-American and Hispanic/
Latino (1) male adolescents who are
attracted to men and report they are HIV
negative or have not been tested and (2)
adult MSM who are recently tested and
verified as HIV-negative.
All study participants will be 13 years
of age or older. Participants will be
recruited in the selected cities through
referrals from Health Departments,
clinics and other HIV testing centers. In
addition, we will recruit via word-of-
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
General Public—Adults .....................
HIV-negative
MSM
Screener—
English.
HIV-negative
MSM
Screener—
Spanish.
HIV-negative MSM Contact Information Form—English.
HIV-negative MSM Contact Information Form—Spanish.
HIV-negative MSM Consent Form—
English.
HIV-negative MSM Consent Form—
Spanish.
HIV-negative MSM Assent for Minors Form—English.
HIV-negative MSM Assent for Minors Form—Spanish.
General Public—Adults .....................
General Public—Adults .....................
asabaliauskas on DSK5VPTVN1PROD with NOTICES
General Public—Adults .....................
General Public—Adults .....................
General Public—Adults .....................
General Public—Adults .....................
General Public—Adults .....................
VerDate Sep<11>2014
17:27 May 12, 2015
Jkt 235001
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
hours
210
1
5/60
18
90
1
5/60
8
105
1
1/60
2
45
1
1/60
1
95
1
5/60
8
35
1
5/60
3
10
1
3/60
1
10
1
3/60
1
E:\FR\FM\13MYN1.SGM
13MYN1
27318
Federal Register / Vol. 80, No. 92 / Wednesday, May 13, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Total
burden
hours
Type of respondent
Form name
General Public—Adults .....................
105
1
1
105
General Public—Adults .....................
HIV-negative MSM In-Depth Interview Guide—English.
HIV-negative In-Depth Interview
Guide—Spanish.
45
1
1
45
Total ...........................................
...........................................................
........................
........................
........................
192
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–11512 Filed 5–12–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–D–0404]
Determination of the Period Covered
by a No-Tobacco-Sale Order and
Compliance With an Order; Draft
Guidance for Tobacco Retailers;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of a draft guidance for
tobacco retailers entitled
‘‘Determination of the Period Covered
by a No-Tobacco-Sale Order and
Compliance With an Order.’’ The draft
guidance, when finalized, will represent
FDA’s current thinking with respect to
imposing no-tobacco-sale orders
(NTSOs) on retailers who have
committed repeated violations of certain
restrictions on the sale and distribution
of tobacco products. This draft guidance
discusses, among other things, the
period of time covered by an NTSO and
a retailer’s compliance with an NTSO.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
on the draft guidance by June 29, 2015.
ADDRESSES: Submit written requests for
single copies of this draft guidance to
the Center for Tobacco Products, Food
and Drug Administration, 10903 New
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:27 May 12, 2015
Jkt 235001
Hampshire Ave., Document Control
Center, Bldg. 71, Rm. G335, Silver
Spring, MD 20993–0002. Send one selfaddressed adhesive label to assist that
office in processing your request or
include a fax number to which the draft
guidance may be sent. See the
SUPPLEMENTARY INFORMATION section for
information on electronic access to the
draft guidance.
Submit electronic comments on the
draft guidance to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. Identify
comments with the docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Colleen Maschal, Center for Tobacco
Products, Food and Drug
Administration, Document Control
Center, Bldg. 71, Rm. G335, 10903 New
Hampshire Ave., Silver Spring, MD
20993, 1–877–287–1373,
colleen.maschal@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
On June 22, 2009, President Obama
signed the Family Smoking Prevention
and Tobacco Control Act (Tobacco
Control Act) (Pub. L. 111–31) into law.
The Tobacco Control Act amended the
Federal Food, Drug, and Cosmetic Act
(the FD&C Act) to give FDA authority to
regulate the manufacture, marketing,
and distribution of tobacco products to
protect public health generally and to
reduce tobacco use by minors. Section
906(d) of the FD&C Act (21 U.S.C.
387f(d)) authorizes FDA to issue
regulations that restrict the sale and
distribution of tobacco products if FDA
determines such regulations would be
appropriate for the protection of the
public health. Section 303(f)(8) of the
FD&C Act (21 U.S.C. 333(f)(8))
authorizes FDA to impose an NTSO
against a person found to have
committed repeated violations, at a
particular retail outlet, of restrictions on
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
the sale and distribution of tobacco
products issued under section 906(d) of
the FD&C Act, such as FDA’s
‘‘Regulations Restricting the Sale and
Distribution of Cigarettes and Smokeless
Tobacco to Protect Children and
Adolescents’’ (21 CFR part 1140). The
term ‘‘no-tobacco-sale order’’ refers to
an order prohibiting the sale of tobacco
products at a retail outlet indefinitely or
for a specified period of time under
section 303(f)(8) of the FD&C Act. A
‘‘repeated violation’’ means ‘‘at least 5
violations of particular requirements
over a 36-month period at a particular
retail outlet that constitute a repeated
violation . . .’’ (section 103(q)(1)(A) of
the Tobacco Control Act).
FDA conducts inspections of retail
outlets to evaluate compliance with the
requirements of the FD&C Act and
implementing regulations. This draft
guidance discusses the period of time to
be covered by an NTSO where there is
evidence of ‘‘repeated violations’’ at a
particular retail outlet. It also discusses
a retailer’s compliance with an NTSO.
This draft guidance is meant to
supplement FDA’s guidances entitled
‘‘Civil Money Penalties and NoTobacco-Sale Orders for Tobacco
Retailers’’ and ‘‘Civil Money Penalties
for Tobacco Retailers and No-TobaccoSale Orders: Responses to Frequently
Asked Questions.’’
II. Significance of Draft Guidance
FDA is issuing this draft guidance
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the Agency’s current thinking
with respect to the period of time to be
covered by NTSOs and retailers’
compliance with NTSOs. It does not
create or confer any rights for or on any
person and does not operate to bind
FDA or the public. An alternative
approach may be used if such approach
satisfies the requirements of the
applicable statutes and regulations.
E:\FR\FM\13MYN1.SGM
13MYN1
]]>Agencies
[Federal Register Volume 80, Number 92 (Wednesday, May 13, 2015)]
[Notices]
[Pages 27316-27318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-11512]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-15-15AGK; Docket No. CDC-2015-0032]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention, CDC, Department of
Health and Human Services, HHS.
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a new information
collection request entitled, ``Understanding Barriers and Facilitators
to HIV prevention for Men Who Have Sex with Men (MSM)'' to conduct
qualitative research with most at risk HIV-negative MSM. The research
is intended to understand issues surrounding HIV risk for MSM, identify
influences of high risk behaviors and to investigate risk management
and resiliency among HIV-negative MSM.
DATES: Written comments must be received on or before July 13, 2015.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0032 by any of the following methods:
Federal eRulemaking Portal: Regulation.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c)
[[Page 27317]]
ways to enhance the quality, utility, and clarity of the information to
be collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information.
Proposed Project
Understanding Barriers and Facilitators to HIV prevention for Men
Who Have Sex with Men (MSM) (Pulse Study)--New--National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP)/Division of HIV/AIDS Prevention (DHAP) is
requesting approval for one year of a data collection entitled,
``Understanding Barriers and Facilitators to HIV prevention for Men Who
Have Sex with Men (MSM).'' The purpose of this study is to conduct
primarily qualitative research with most at risk HIV-negative MSM.
There are four goals to this study: (1) Understand issues surrounding
HIV risk for MSM; (2) learn more about how gay community or peer norms,
and community identification influence risk behaviors; (3) understand
individual HIV risk management, such as having an HIV-positive partner
with suppressed viral load, barriers and facilitators for use of
biomedical interventions (i.e., pre-exposure prophylaxis (PrEP), non-
occupational post-exposure prophylaxis (nPEP); and (4) understand
factors that promote resiliency among HIV-negative MSM.
The present research will be conducted in the top five Southern
metropolitan areas in the United States with the highest HIV diagnoses
for MSM--Atlanta, Georgia; Jackson, Mississippi; Miami, Florida; and
New Orleans and Baton Rouge, Louisiana. These cities rank among those
in the South with the highest prevalence and incidence of HIV and
sexually transmitted infections (STIs) among black/African American and
Hispanic/Latino MSM.
The study population will consist of black/African-American and
Hispanic/Latino (1) male adolescents who are attracted to men and
report they are HIV negative or have not been tested and (2) adult MSM
who are recently tested and verified as HIV-negative.
All study participants will be 13 years of age or older.
Participants will be recruited in the selected cities through referrals
from Health Departments, clinics and other HIV testing centers. In
addition, we will recruit via word-of-mouth referrals or flyers given
out by community-based, advocacy, faith-based, and service-providing
agencies.
Primarily, we will use a qualitative research design and will
include a brief quantitative survey to reduce participant burden where
possible (for example, when we do not need to know an in-depth answer
for socio-demographics, HIV testing history, housing status, health
insurance status). The first portion of the interview instrument
consists of brief structured questions to characterize the respondents.
The second portion of the instrument consists of open-ended in-depth
qualitative questions. This research design was chosen based on the
exploratory nature of our study purpose.
All data collection tools will be pre-tested and interviews
conducted by trained personnel. The data collection will take place at
a time and place that is convenient to the respondent. Locations will
be private. Data collection may be audio-recorded and transcribed with
the consent of the respondent.
We anticipate that consent forms and screener forms to take five
minutes to complete each. We anticipate 50 percent of HIV-negative MSM
screened will be eligible for the study. The brief structured survey
(15 minutes) and in-depth interview (45 minutes) for HIV-negative MSM
are expected to take a total of 60 minutes (1 hour) total. We will
complete interviews for 105 black/African-American and 45 Hispanic/
Latino HIV-negative MSM at greatest risk for HIV in high prevalence
cities in the U.S. South. We anticipate screening 300 potential
respondents. The total number of burden hours are 192.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
General Public--Adults........ HIV-negative MSM 210 1 5/60 18
Screener--Engli
sh.
General Public--Adults........ HIV-negative MSM 90 1 5/60 8
Screener--Spani
sh.
General Public--Adults........ HIV-negative MSM 105 1 1/60 2
Contact
Information
Form--English.
General Public--Adults........ HIV-negative MSM 45 1 1/60 1
Contact
Information
Form--Spanish.
General Public--Adults........ HIV-negative MSM 95 1 5/60 8
Consent Form--
English.
General Public--Adults........ HIV-negative MSM 35 1 5/60 3
Consent Form--
Spanish.
General Public--Adults........ HIV-negative MSM 10 1 3/60 1
Assent for
Minors Form--
English.
General Public--Adults........ HIV-negative MSM 10 1 3/60 1
Assent for
Minors Form--
Spanish.
[[Page 27318]]
General Public--Adults........ HIV-negative MSM 105 1 1 105
In-Depth
Interview
Guide--English.
General Public--Adults........ HIV-negative In- 45 1 1 45
Depth Interview
Guide--Spanish.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 192
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-11512 Filed 5-12-15; 8:45 am]
BILLING CODE 4163-18-P
